CELC Stock Analysis: Buy, Sell, or Hold?

CELC - Celcuity Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$99.95
4.02 (4.19%) ▲
5d: +13.89%
30d: -25.39%
90d: -12.94%
BUY
HIGH Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Smart Money Distribution

None View Scanner →

Strength: 4.7/10

Get Alerted When CELC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: CELC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$25.92
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$16.10
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CELC is currently trading at $99.95, which is considered fair relative to its 30-day fair value range of $84.86 to $127.86. The stock's valuation (Forward PE: 135.1) is in line with its historical norms (143.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CELC is showing sideways momentum. The price is approaching resistance at $101.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.2% recently.

Market Sentiment: CELC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $161.09 (+61.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $84.86 - $127.86
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 88.1%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.2%)
  • BULLISH: Trading 61.2% below Wall St target ($161.09)

Trading Range Analysis

30-Day Trading Range $84.86 - $127.86
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $82.55
Resistance Level $101.29
Current Trend Sideways
Technical data as of Jun 26, 2026

Fundamental Context

Forward P/E (Next Year Est.) 135.07
Wall Street Target $161.09 (+61.2%)
Valuation Discount vs History -2.1% cheaper
PE vs Historical 135.1 vs 143.8 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -2.1% (market-implied from PE analysis)
1-Year Target $97.85 (-2%)
2-Year Target $95.80 (-4%)
3-Year Target $93.78 (-6%)
3-Yr Target (if PE normalizes) (PE: 135→144) $99.85 (0%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 135.1 to 143.8
Stabilization Target: $106.41 (+6.5%)
PE Expansion Potential: +6.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 28, 2026 1:05 PM ET
Data refreshes hourly during market hours. Next update: 2:05 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard E Buller SELL 3000 shares 2026-03-31
David Dalvey SELL 20000 shares 2026-01-27

Unlock Insider Activity

See real-time buying/selling by company executives for CELC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$276 59 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$106 61 BUY
INCY
Incyte Corporation
HOLD
27 analysts
$110 67 BUY
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$93 56 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$83 60 HOLD

Advanced CELC Option Strategies

Professional options setups generated by AI based on today's CELC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CELC

CELC Technical Chart CELC Price Prediction CELC Earnings Date CELC Investment Advisor CELC Fair Price Analyzer CELC Options Advisor CELC Options Chain CELC Options Analysis CELC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals